Coloplast: Finally Getting Buyable
Coloplast is a global leader in specialized intimate healthcare, with strong innovation, high margins, and a defensible moat in core segments. Despite a 20% share price drop, I see upside potential, but only at a conservative 25x P/E due to risks in commoditized segments and M&A. Current fundamentals are solid: strong organic growth, robust dividend, and on-track 2025E results, but margin expansion is likely capped.
Coloplast A/S (CLPBF) Q2 2025 Earnings Call Transcript
Coloplast A/S (OTCPK:CLPBF) Q2 2025 Earnings Conference Call May 6, 2025 5:00 AM ET Company Participants Lars Søren Rasmussen - Interim CEO Anders Lonning-Skovgaard - Chief Financial Officer Conference Call Participants Operator Ladies and gentlemen, welcome to the Coloplast First Half 2024-2025 Earnings Release Conference Call. I am Hilda, the Chorus Call operator.
Coloplast A/S (CLPBF) Q1 2025 Earnings Call Transcript
Coloplast A/S (OTCPK:CLPBF) Q1 2025 Results Conference Call February 4, 2025 5:00 AM ET Company Participants Kristian Villumsen - Chief Executive Officer Anders Lonning-Skovgaard - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Jack Reynolds-Clark - RBC Capital Markets Richard Felton - GS Lisa Clive - Bernstein Julien Dormois - Jefferies Maja Pataki - Kepler Cheuvreux Niels Granholm-Leth - Carnegie Aisyah Noor - Morgan Stanley Marianne Bulot - Bank of America Martin Brenoe - Nordea Giang Nguyen - Citi Carsten Lonborg Madsen - Danske Bank Operator Ladies and gentlemen, welcome to the Coloplast A/S Q1 2024-'25 Earnings Release Conference Call. I'm Valentina, the Chorus Call operator.
Coloplast A/S (CLPBF) Q4 2024 Earnings Call Transcript
Coloplast A/S (OTCPK:CLPBF) Q4 2024 Earnings Conference Call November 5, 2024 5:00 AM ET Company Participants Nicholas Seibert - Vice President of Corporate Development & Investor Relations Kristian Villumsen - Chief Executive Officer Anders Lonning-Skovgaard - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Jack Reynolds-Clark - RBC Martin Parkhoi - SEB Julien Dormois - Jefferies Aisyah Noor - Morgan Stanley Oliver Metzger - ODDO Mattias Haggblom - Handelsbanken Doyle Graham - UBS Anchal Verma - JPMorgan Operator Ladies and gentlemen, welcome to the full year 2023-2024 conference call. I am Maria, the Chorus Call operator.
Recent Price Trend in Coloplast A/S Sponsored ADR (CLPBY) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Coloplast A/S Sponsored ADR (CLPBY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Coloplast A/S (CLPBF) Q3 2024 Earnings Call Transcript
Coloplast A/S (OTCPK:CLPBF) Q3 2024 Earnings Conference Call August 20, 2024 5:00 AM ET Company Participants Kristian Villumsen - President and Chief Executive Officer Anders Lonning-Skovgaard - Executive Vice President and Chief Financial Officer Conference Call Participants Jack Reynolds - RBC Capital Markets Anchal Verma - JPMorgan Maja Pataki - Kepler Cheuvreux Niels Granholm - Carnegie Veronika Dubajova - Citi Aisyah Noor - Morgan Stanley Marianne Bulot - Bank of America Christian Ryom - Danske Bank Shubhangi Gupta - HSBC Marco Cox - Barclays Operator Ladies and gentlemen, welcome to the Coloplast Nine Months 2023-2024 Earnings Release Conference Call. I am Shari, the Chorus Call operator.
